Christofides N D, Sheehan C P, Midgley J E
Amerlite Diagnostics Ltd., Cardiff Laboratories, Whitchurch, U.K.
Clin Chem. 1992 Jan;38(1):11-8.
We describe a one-step, labeled-antibody radioassay for measuring free thyroxin (FT4) in serum or plasma, based on a novel principle. FT4 in the sample competes with a gross molar excess (over antibody) of a cross-reactant (L-triiodothyronine, T3), chemically coupled to magnetizable polymer particles, for binding to avid 125l-labeled monoclonal anti-thyroxin antibodies. As in conventional immunoassays, 125I counts bound to the solid phase (T3-magnetizable particles) are inversely proportional to sample FT4 concentration. We demonstrate here the development and technical validity of this new method.
我们基于一种新原理,描述了一种用于测量血清或血浆中游离甲状腺素(FT4)的一步法标记抗体放射测定法。样品中的FT4与化学偶联到可磁化聚合物颗粒上的交叉反应物(L-三碘甲状腺原氨酸,T3)的总摩尔过量(相对于抗体)竞争,以结合到avid 125I标记的单克隆抗甲状腺素抗体上。与传统免疫测定法一样,与固相(T3-可磁化颗粒)结合的125I计数与样品FT4浓度成反比。我们在此展示了这种新方法的开发及其技术有效性。